McDermott Will & Schulte, a global law firm

H. Michael (Mike) Byrne has extensive experience in complex insurance transactions, regulation and InsurTech matters. He advises US and international insurers and reinsurers, investors, producers and technology companies on a broad range of matters, including obtaining regulatory approvals and conducting due diligence for M&A; obtaining approvals for affiliate transactions; forming, licensing and structuring business operations; drafting and negotiating distribution and administration agreements; and developing and obtaining approvals for unique products. He delivers practical and business-focused counsel on novel issues.

Mike frequently presents on InsurTech and excess and surplus lines. He maintains a broad practice across the US with a global client base and network.

Michael R. Halsband has more than 35 years of leadership experience in the insurance and reinsurance industry, including in investment banking and capital markets. He is the global leader of the firm’s Insurance Transactions and Regulation Group.

His wide-ranging experience includes insurance broker and carrier M&A, new company formation, financings, capital raises, and new product development (principally for InsurTech startups); complex structured (re)insurance transactions; insurance-linked securities (ILS); distressed portfolio run-off administration and general corporate insurance regulatory matters.

His broad industry knowledge comes from his experience as an executive and investment banker spearheading key business initiatives at Sirius Group, Goldman Sachs, Deutsche Bank, and Alea Group.

Over the course of his career, Michael has built an innovative transactional practice and is valued by clients as much for his guidance on legal issues as his pragmatic and effective business acumen.

Brian M. Gordon represents venture-backed technology and digital health companies in acquisitions, financing transactions, the negotiation of credit facilities, corporate governance, employment, and equity compensation matters and in the resolution of day-to-day legal issues. He also represents investors in venture, growth, and strategic financings.

Brian has significant experience representing private equity funds in the financing, acquisition, and disposition of portfolio companies, in both control and non-control transactions. He counsels strategic buyers and sellers in mergers and acquisitions (M&A) transactions.

As a member of the Transactions Group, Brian works closely with the Firm’s health & life sciences lawyers to provide seamless representation on corporate and regulatory issues related to digital health, health IT, and other healthcare companies.